Literature DB >> 6394338

Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin.

P D Mooy, H Przyrembel, M A Giesberts, H R Scholte, W Blom, H H van Gelderen.   

Abstract

A boy, now 22 months old, is described who presented at the age of 6 weeks with hypoglycaemic coma. The excretion pattern of organic acids in the urine was consistent with glutaric aciduria type II (GA II). A high energy diet low in fat and protein was given. Treatment with riboflavine resulted in an improvement of the metabolite profile, and the patient gained weight. However, a tendency to hypoglycaemia and severe hypotonia persisted. Due to muscle weakness, aggravated by infections, artificial ventilation was necessary during three periods. Serum carnitine level was low. Treatment with carnitine, started during the third period of artificial ventilation, led to some improvement of muscle strength, but he still could not breathe without support. Treatment with insulin, combined with further enrichment of the diet with glucose, resulted in an increase in muscular strength and in weight gain. Thirteen families with GA II have been described upto now. This is the first patient with a severe form of the disorder wo has survived the 1st year of life. Treatment and metabolic studies are presented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6394338     DOI: 10.1007/BF00445792

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Glutaric aciduria type II: multiple defects in isolated muscle mitochondria and deficient beta-oxidation in fibroblasts.

Authors:  P D Mooy; M A Giesberts; H H van Gelderen; H R Scholte; I E Luyt-Houwen; H Przyrembel; W Blom
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

2.  C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.

Authors:  N Gregersen; H Wintzensen; S K Christensen; M F Christensen; N J Brandt; K Rasmussen
Journal:  Pediatr Res       Date:  1982-10       Impact factor: 3.756

3.  Hypoketosis as a cause of symptoms in childhood hypoglycemia.

Authors:  H L Teijema; H H van Gelderen; M A Giesberts
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183

4.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

5.  Glutaric aciduria Type II.

Authors:  L Sweetman; W L Nyhan; D A Tauner; T A Merritt; M Singh
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

6.  Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II.

Authors:  N Gregersen; S Kølvraa; K Rasmussen; E Christensen; N J Brandt; F Ebbesen; F H Hansen
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

7.  Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide.

Authors:  A Niederwieser; B Steinmann; U Exner; F Neuheiser; U Redweik; M Wang; S Rampini; U Wendel
Journal:  Helv Paediatr Acta       Date:  1983-03

8.  Ethylmalonic-adipic aciduria. In vivo and in vitro studies indicating deficiency of activities of multiple acyl-CoA dehydrogenases.

Authors:  S Mantagos; M Genel; K Tanaka
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

9.  Glutaric aciduria type II: in vitro studies on substrate oxidation, acyl-CoA dehydrogenases, and electron-transferring flavoprotein in cultured skin fibroblasts.

Authors:  W Rhead; S Mantagos; K Tanaka
Journal:  Pediatr Res       Date:  1980-12       Impact factor: 3.756

10.  Recurrent hypoglycemia associated with glutaric aciduria type II in an adult.

Authors:  G Dusheiko; M C Kew; B I Joffe; J R Lewin; S Mantagos; K Tanaka
Journal:  N Engl J Med       Date:  1979-12-27       Impact factor: 91.245

View more
  6 in total

1.  Acylcoenzyme A dehydrogenase deficiency in heart tissue from infants who died unexpectedly with fatty change in the liver.

Authors:  F Allison; M J Bennett; S Variend; P C Engel
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

Review 2.  Therapy of mitochondrial disorders.

Authors:  H Przyrembel
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts.

Authors:  B A Amendt; W J Rhead
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Cystic renal dysplasia as a leading sign of inherited metabolic disease.

Authors:  Felix Distelmaier; Markus Vogel; Ute Spiekerkötter; Klaus Gempel; Dirk Klee; Stefan Braunstein; Heinz-Peter Groneck; Ertan Mayatepek; Udo Wendel; Bernd Schwahn
Journal:  Pediatr Nephrol       Date:  2007-07-19       Impact factor: 3.714

Review 5.  Glutaric Acidemia, Pathogenesis and Nutritional Therapy.

Authors:  Qian Li; Chunlan Yang; Lijuan Feng; Yazi Zhao; Yong Su; Hong Liu; Hongkang Men; Yan Huang; Heinrich Körner; Xinming Wang
Journal:  Front Nutr       Date:  2021-12-15

6.  Glutaric aciduria type 2 presenting with acute respiratory failure in an adult.

Authors:  Ebru Ortac Ersoy; Dorina Rama; Özlem Ünal; Serap Sivri; Arzu Topeli
Journal:  Respir Med Case Rep       Date:  2015-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.